# AXCELIS TECHNOLOGIES INC (ACLS) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from AXCELIS TECHNOLOGIES INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ACLS/mda/fy2025/): filed 2026-02-26; accession 0001104659-26-020461 (https://www.sec.gov/Archives/edgar/data/1113232/000110465926020461/acls-20251231x10k.htm); latest 10-K
- [FY 2024 MD&A](/company/ACLS/mda/fy2024/): filed 2025-02-28; accession 0001558370-25-001855 (https://www.sec.gov/Archives/edgar/data/1113232/000155837025001855/acls-20241231x10k.htm)
- [FY 2023 MD&A](/company/ACLS/mda/fy2023/): filed 2024-02-23; accession 0001558370-24-001628 (https://www.sec.gov/Archives/edgar/data/1113232/000155837024001628/acls-20231231x10k.htm)
- [FY 2022 MD&A](/company/ACLS/mda/fy2022/): filed 2023-02-24; accession 0001558370-23-002006 (https://www.sec.gov/Archives/edgar/data/1113232/000155837023002006/acls-20221231x10k.htm)
- [FY 2021 MD&A](/company/ACLS/mda/fy2021/): filed 2022-02-25; accession 0001558370-22-002096 (https://www.sec.gov/Archives/edgar/data/1113232/000155837022002096/acls-20211231x10k.htm)

Back to /company/ACLS/